Advancing the conversation on obesity medicine
The 7th Edition World Congress on Endocrinology, Diabetes and Metabolism brought physicians, researchers and academic speakers to Barcelona from June 22 to 24, 2026. Dr. Pabona spoke in Scientific Session I on June 22.
His talk framed obesity as a complex metabolic condition that often calls for a broader, physician-led approach than weight reduction alone. The proceedings list it as “GLP-1-Based Therapies and Beyond: Integrating metabolic modulation, hormone optimization, and longevity medicine in obesity management.”
What the abstract covers
The published program abstract describes obesity as a chronic, relapsing, multifactorial metabolic disease. It notes that incretin-based medicines, including GLP-1 receptor agonists and dual GLP-1/GIP agonists, have advanced treatment, while weight regain, loss of lean mass and incomplete metabolic recovery still limit long-term success. The talk proposed a physiology-driven framework that looks at:
- Endocrine pathways: insulin signaling, the hypothalamic-pituitary-adrenal (HPA) axis, thyroid function and sex hormone balance
- Preserving lean muscle mass, supporting mitochondrial function and lowering chronic low-grade inflammation
- Nutrition, resistance training and other adjunct strategies to limit side effects and support long-term outcomes
- Clinical protocols, patient selection, safety and plans to prevent weight regain after therapy
These are research and teaching topics from a scientific session, not a promise of results for any patient.
The conference record
- Event: 7th Edition World Congress on Endocrinology, Diabetes and Metabolism
- Date and place: June 22–24, 2026, Barcelona, Spain
- Session: Scientific Session I, June 22, 2026, 11:00–11:20
- Recognition: certificate of recognition for his oral presentation
- Proceedings: title proof identifying his presentation
Earlier international talks
Barcelona continued a run of international presentations on endocrinology, diabetes, metabolism and obesity:
- 5th Edition World Congress on Endocrinology, Diabetes, and Metabolism, Vienna, Austria, July 2024
- 8th International Conference on Obesity and Chronic Diseases, London, United Kingdom, November 2024
Closer to home, he has discussed weight loss beyond the scale on Arkansas Style and in other interviews.
Scheduled AAAM Congress presentations
Dr. Pabona is scheduled to speak at the American Academy of Aesthetic Medicine (AAAM) Congress in Miami on November 13 and 15, 2026. The AAAM scientific program lists presentations on multimodal facial rejuvenation in Fitzpatrick skin type IV and on metabolic, hormone and longevity topics in obesity management.
What this means for your care
International academic work supports the same approach you get at Embrace Eternal Beauty:
- Medical evaluation first. Candidacy, safety considerations and expected outcomes are decided at a medical consultation.
- Metabolic context. The talk looked at obesity through metabolic health, hormones, muscle preservation and longevity-focused care.
- Individualized planning. Care is monitored over time, without one-size-fits-all promises or guaranteed outcomes.
Explore physician-led medical weight loss, hormone replacement therapy or a skin consultation. Learn more about Dr. Pabona’s background, or see his separate awards and recognition.
Questions
Frequently asked questions
What is EDM 2026?
EDM 2026 is the 7th Edition World Congress on Endocrinology, Diabetes and Metabolism, held in Barcelona, Spain, from June 22 to 24, 2026. It brought together physicians, researchers and academic speakers. Dr. Pabona gave an oral presentation in Scientific Session I on June 22 and received a certificate of recognition for it.
What did Dr. Pabona present at EDM 2026?
His talk, “GLP-1-Based Therapies and Beyond,” covered integrating metabolic modulation, hormone optimization and longevity medicine in obesity management. It looked at why weight regain and loss of lean mass limit long-term results with GLP-1 medicines, and how endocrine pathways, nutrition and resistance training fit into an individualized, physician-led plan.
Where else has Dr. Pabona spoken internationally?
Before Barcelona, Dr. Pabona spoke at the 5th Edition World Congress on Endocrinology, Diabetes, and Metabolism in Vienna, Austria, in July 2024, and at the 8th International Conference on Obesity and Chronic Diseases in London in November 2024. He is scheduled to present at the AAAM Congress in Miami on November 13 and 15, 2026.
How does this research affect my treatment at Embrace Eternal Beauty?
It shapes the approach, not a promise. Any weight loss, hormone or wellness plan starts with a medical consultation where Dr. Pabona reviews your goals, health history and candidacy. Prescription treatment is considered only when it’s medically appropriate, and your plan is monitored over time. Results vary from person to person.

